Your browser doesn't support javascript.
loading
Corrigendum to "Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the Strategic Reperfusion Early After Myocardial infarction trial" [Am Heart J 169/6 (2015) 890-898].
Armstrong, Paul W; Zheng, Yinggan; Westerhout, Cynthia M; Rosell-Ortiz, Fernado; Sinnaeve, Peter; Lambert, Yves; Lopes, Renato D; Bluhmki, Erich; Danays, Thierry; Van de Werf, Frans.
Afiliação
  • Armstrong PW; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada. Electronic address: paul.armstrong@ualberta.ca.
  • Zheng Y; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.
  • Westerhout CM; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.
  • Rosell-Ortiz F; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.
  • Sinnaeve P; Empresa Pública de Emergencias Sanitarias, Almería, Spain.
  • Lambert Y; Department of Cardiology, University Hospital Gasthuisberg, Leuven, Belgium.
  • Lopes RD; Centre Hospitalier de Versailles, SAMU 78 and Mobile Intensive Care Unit, Versailles, France.
  • Bluhmki E; Duke University Medical Centre, Duke Clinical Research Institute, Durham, NC.
  • Danays T; Boehringer Ingelheim, Berkshire, UK.
  • Van de Werf F; Boehringer Ingelheim France, Reims, France.
Am Heart J ; 184: 157, 2017 02.
Article em En | MEDLINE | ID: mdl-28224932

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article